PCVX icon

Vaxcyte
PCVX

Overview Fund Activity

250 hedge funds and large institutions have $8.13B invested in Vaxcyte in 2024 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 102 increasing their positions, 77 reducing their positions, and 18 closing their positions.

Holders
250
Holders Change
+27
Holders Change %
+12.11%
% of All Funds
3.62%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.17%
New
47
Increased
102
Reduced
77
Closed
18
Calls
$16.7M
Puts
$12.2M
Net Calls
+$4.53M
Net Calls Change
-$2.42M

Top Buyers

1
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$243M
2
DGM
2
Darwin Global Management
Jersey
$188M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$1.11B
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$665M
5
PBA
5
Paradigm Biocapital Advisors
New York
$84.7M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$33.5M
2
Millennium Management
2
Millennium Management
New York
$14.1M
3
VPC
3
Vestal Point Capital
New York
$0
4
GPP
4
Great Point Partners
Connecticut
$0
5
Pictet Asset Management
5
Pictet Asset Management
Switzerland
$58.9M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.11B 16,261,159 +2,047,794 +14%
Vanguard Group
2
Vanguard Group
Pennsylvania
$665M 9,737,254 +1,284,883 +15%
BlackRock
3
BlackRock
New York
$650M 9,513,007 +937,160 +11%
RCM
4
RA Capital Management
Massachusetts
$560M 8,203,754 +312,500 +4%
Janus Henderson Group
5
Janus Henderson Group
United Kingdom
$524M 7,673,868 +692,492 +10%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$336M 4,919,370 +487,450 +11%
Capital Research Global Investors
7
Capital Research Global Investors
California
$283M 4,140,521 +700,414 +20%
T. Rowe Price Investment Management
8
T. Rowe Price Investment Management
Maryland
$243M 3,552,967 +2,306,926 +185%
State Street
9
State Street
Massachusetts
$228M 3,337,092 -52,436 -2%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$217M 3,176,181 +498,359 +19%
DGM
11
Darwin Global Management
Jersey
$188M 2,750,804 +2,170,845 +374%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$156M 2,287,375 +313,869 +16%
Franklin Resources
13
Franklin Resources
California
$147M 2,147,656 +1,070,736 +99%
PA
14
Perceptive Advisors
New York
$132M 1,932,759 +844,273 +78%
DCM
15
Driehaus Capital Management
Illinois
$128M 1,867,807 +193,439 +12%
AllianceBernstein
16
AllianceBernstein
Tennessee
$122M 1,780,703 -134,344 -7%
Westfield Capital Management
17
Westfield Capital Management
Massachusetts
$108M 1,586,095 +130,502 +9%
FAM
18
Fred Alger Management
New York
$95.4M 1,396,711 -273,478 -16%
Jennison Associates
19
Jennison Associates
New York
$85.9M 1,256,883 -219,271 -15%
PBA
20
Paradigm Biocapital Advisors
New York
$84.7M 1,239,995 +1,239,995 New
Invesco
21
Invesco
Georgia
$84.3M 1,234,509 +1,007,558 +444%
B
22
Braidwell
Connecticut
$82.8M 1,212,703 -77,262 -6%
JPMorgan Chase & Co
23
JPMorgan Chase & Co
New York
$79.4M 1,161,777 +756,443 +187%
FLSM
24
Frazier Life Sciences Management
California
$77.8M 1,139,405 -25,000 -2%
O
25
OrbiMed
New York
$72.8M 1,066,131 -86,960 -8%
1
2 3 4 5